Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

TOI — The Oncology Institute, Inc. Dilution Risk Tracker

Track TOI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TOI — Get alerts when the score changes →

As of October 13, 2026, The Oncology Institute, Inc. (TOI) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. The Oncology Institute, Inc. has a market capitalization of $468.92M, 101.92M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
95
📊 Float Risk
5
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 34%
💰 Capital Raise model 55%
• Critical: only 0.1 months cash remaining
🔄 Reverse Split model est. 15%
• Only 0 months cash — financial pressure
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track TOI — Get forecast alerts →

Market Data

Market Cap$468.92M
Shares Outstanding101.92M
Float87.41M
Cash$200.0K
Debt$80.05M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding101.92MVerified float table or market cache
Public Float87.41MVerified float table or market cache
Market Cap$468.92MMarket data cache
Cash Runway0.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

46.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track TOI for full holder detail →

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-12
xbrl XBRL WARRANT 2026-03-12
4 INSIDER TRANSACTION 2026-04-01
4 INSIDER TRANSACTION 2026-04-01
4 INSIDER TRANSACTION 2026-04-01
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TOI Dilution Snapshot

The Oncology Institute, Inc. (TOI) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TOI's DilutionScore has held steady at 65/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202665/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TOI shares outstanding have increased 1.2% from 98.84M (Mar 2026) to 99.98M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 202699.98M87.41M▼ 0.08%
May 18, 202699.98M87.47M▲ 6.64%
May 15, 202699.98M82.03M▲ 0.25%
May 11, 202699.98M81.82M▲ 9.04%
May 08, 202699.98M75.04M▲ 15.58%
Apr 26, 202698.84M64.93M▲ 0.15%
Apr 15, 202698.84M64.83M▼ 0.03%
Apr 13, 202698.84M64.85M▲ 0.17%
Apr 03, 202698.84M64.74M▼ 0.04%
Mar 30, 202698.84M64.77M▼ 0.08%
Mar 28, 202698.84M64.82M▼ 0.19%
Mar 26, 202698.84M64.94M▼ 0.04%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TOI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TOI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TOI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TOI
TOI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.